Patents by Inventor Rainer Pape

Rainer Pape has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11401300
    Abstract: A process for purifying fibrinogen from a fibrinogen containing source by precipitation of fibrinogen by a precipitating agent from a fibrinogen containing solution in the presence of one or more chelating agent(s) and removal of the supernatant from the fibrinogen paste, characterised in that fibrinogen is extracted from the paste forming a liquid fraction containing fibrinogen, and an undissolved residue, which is separated from the liquid.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: August 2, 2022
    Assignee: OCTAPHARMA AG
    Inventors: Petra Schulz, Werner Gehringer, Friedrich Schön, Caroline Leitinger, Jürgen Römisch, Rainer Pape
  • Publication number: 20190016755
    Abstract: A process for purifying fibrinogen from a fibrinogen containing source by precipitation of fibrinogen by a precipitating agent from a fibrinogen containing solution in the presence of one or more chelating agent(s) and removal of the supernatant from the fibrinogen paste, characterised in that fibrinogen is extracted from the paste forming a liquid fraction containing fibrinogen, and an undissolved residue, which is separated from the liquid.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 17, 2019
    Applicant: OCTAPHARMA AG
    Inventors: Petra Schulz, Werner Gehringer, Friedrich Schön, Caroline Leitinger, Jürgen Römisch, Rainer Pape
  • Patent number: 10112972
    Abstract: A process for purifying fibrinogen from a fibrinogen containing source by precipitation of fibrinogen by a precipitating agent from a fibrinogen containing solution in the presence of one or more chelating agent(s) and removal of the supernatant from the fibrinogen paste, characterized in that fibrinogen is extracted from the paste forming a liquid fraction containing fibrinogen, and an undissolved residue, which is separated from the liquid.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: October 30, 2018
    Assignee: OCTAPHARMA AG
    Inventors: Petra Schulz, Werner Gehringer, Friedrich Schön, Caroline Leitinger, Jürgen Römisch, Rainer Pape
  • Patent number: 9938318
    Abstract: The present invention relates to a method or process for the manufacture of a virus and prion save native fibrinogen concentrate of high purity and low amounts of fibrinopeptide A and fibronectin.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: April 10, 2018
    Assignee: OCTAPHARMA AG
    Inventors: Petra Schulz, Rainer Pape, Werner Gehringer
  • Publication number: 20160264619
    Abstract: The present invention relates to a method or process for the manufacture of a virus and prion save native fibrinogen concentrate of high purity and low amounts of fibrinopeptide A and fibronectin.
    Type: Application
    Filed: May 25, 2016
    Publication date: September 15, 2016
    Applicant: OCTAPHARMA AG
    Inventors: Petra Schulz, Rainer Pape, Werner Gehringer
  • Patent number: 9371355
    Abstract: The present invention relates to a method or process for the manufacture of a virus and prion save native fibrinogen concentrate of high purity and low amounts of fibrinopeptide A and fibronectin.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: June 21, 2016
    Assignee: OCTAPHARMA AG
    Inventors: Petra Schulz, Rainer Pape, Werner Gehringer
  • Publication number: 20150045539
    Abstract: A process for purifying fibrinogen from a fibrinogen containing source by precipitation of fibrinogen by a precipitating agent from a fibrinogen containing solution in the presence of one or more chelating agent(s) and removal of the supernatant from the fibrinogen paste, characterised in that fibrinogen is extracted from the paste forming a liquid fraction containing fibrinogen, and an undissolved residue, which is separated from the liquid.
    Type: Application
    Filed: March 12, 2013
    Publication date: February 12, 2015
    Inventors: Petra Schulz, Werner Ghringer, Friedrich Schön, Caroline Leitinger, Jürgen Römisch, Rainer Pape
  • Publication number: 20130274444
    Abstract: The present invention relates to a method or process for the manufacture of a virus and prion save native fibrinogen concentrate of high purity and low amounts of fibrinopeptide A and fibronectin.
    Type: Application
    Filed: September 20, 2011
    Publication date: October 17, 2013
    Applicant: OCTAPHARMA AG
    Inventors: Petra Schulz, Rainer Pape, Werner Gehringer